SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 50.56 |
| Enterprise Value ($M) | 36.72 |
| Book Value ($M) | -55.07 |
| Book Value / Share | -9.30 |
| Price / Book | -0.92 |
| NCAV ($M) | -89.93 |
| NCAV / Share | -15.18 |
| Price / NCAV | -0.56 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.09 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.35 |
| Current Ratio | 0.57 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 27.18 |
| Assets | 62.04 |
| Liabilities | 117.11 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 128.94 |
| Operating Income | -78.33 |
| Net Income | -85.40 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -68.72 |
| Cash from Investing | 8.62 |
| Cash from Financing | 59.28 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Redmile Group, LLC | 9.90 | 17.29 | |
| 13G | Panacea Innovation Ltd | 9.50 | ||
| 13G/A | Citadel Advisors Llc | 4.60 | ||
| 13G/A | EcoR1 Capital, LLC | 9.99 | -95.10 | |
| 13G/A | Vanguard Group Inc | 3.18 | 0.00 | |
| 13D/A | Adiumentum Capital Fund I LP | 19.99 | -85.94 | |
| 13G/A | BlackRock, Inc. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 12,838 | 61,155 | 20.99 | |
| 9,357 | 63,539 | 14.73 | |
| 17,321 | 90,230 | 19.20 | |
| 12,575 | 52,411 | 23.99 | |
| 13,101 | 78,490 | 16.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ARVN – Arvinas, Inc. | ARWR – Arrowhead Pharmaceuticals, Inc. |
| ASMB – Assembly Biosciences, Inc. | AVIR – Atea Pharmaceuticals, Inc. |
| AVXL – Anavex Life Sciences Corp. |
Financial data and stock pages provided by
Fintel.io